Avidity Biosciences, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC RNAM

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

188,807

Value ($000)

13,619

Weight

0.0%

2021 Q3 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	13,619	0.0%	188,807	12/31/2025
2025 Q3	11/14/2025	7,581	0.0%	173,995	9/30/2025
2025 Q2	8/14/2025	11,245	0.0%	395,965	6/30/2025
2025 Q1	5/19/2025	10,560	0.0%	357,718	3/31/2025
2024 Q4	2/14/2025	9,666	0.0%	332,389	12/31/2024
2024 Q3	11/14/2024	16,022	0.0%	348,841	9/30/2024
2024 Q2	8/14/2024	14,312	0.0%	350,365	6/30/2024
2024 Q1	5/15/2024	2,049	0.0%	80,298	3/31/2024
2023 Q4	2/14/2024	825	0.0%	91,165	12/31/2023
2023 Q3	11/13/2023	582	0.0%	91,165	9/30/2023
2023 Q2	8/11/2023	864	0.0%	56,306	6/30/2023
2023 Q1	5/15/2023	864	0.0%	56,306	3/31/2023
2022 Q4	2/14/2023	1,335	0.0%	60,177	12/31/2022
2022 Q3	11/14/2022	387	0.0%	23,722	9/30/2022
2022 Q2	8/12/2022	345	0.0%	23,722	6/30/2022
2022 Q1	5/16/2022	438	0.0%	23,722	3/31/2022
2021 Q4	2/14/2022	791	0.0%	33,278	12/31/2021
2021 Q3	11/15/2021	235	0.0%	9,556	9/30/2021